A new trading day began on Tuesday, with CorMedix Inc (NASDAQ: CRMD) stock price down -7.63% from the previous day of trading, before settling in for the closing price of $12.19. CRMD’s price has ranged from $5.60 to $17.43 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 29.80% over the past five years. Meanwhile, its annual earnings per share averaged 1006.29%. With a float of $69.26 million, this company’s outstanding shares have now reached $78.35 million.
CorMedix Inc (CRMD) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of CorMedix Inc is 12.09%, while institutional ownership is 56.57%. The most recent insider transaction that took place on Dec 30 ’25, was worth 260,000. In this transaction Director of this company sold 20,000 shares at a rate of $13.00, taking the stock ownership to the 40,250 shares. Before that another transaction happened on Dec 30 ’25, when Company’s Director proposed sale 20,000 for $12.97, making the entire transaction worth $259,400.
CorMedix Inc (CRMD) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 0.22 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.72 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1006.29% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
Here are CorMedix Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.14. Likewise, its price to free cash flow for the trailing twelve months is 11.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.05, a number that is poised to hit 0.84 in the next quarter and is forecasted to reach 2.54 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
CorMedix Inc (NASDAQ: CRMD) saw its 5-day average volume 2.88 million, a positive change from its year-to-date volume of 2.84 million. As of the previous 9 days, the stock’s Stochastic %D was 27.70%.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 35.76%, which indicates a significant increase from 3.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.54 in the past 14 days, which was lower than the 0.61 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.12, while its 200-day Moving Average is $11.29. Nevertheless, the first resistance level for the watch stands at $11.97 in the near term. At $12.68, the stock is likely to face the second major resistance level. The third major resistance level sits at $13.07. If the price goes on to break the first support level at $10.87, it is likely to go to the next support level at $10.48. The third support level lies at $9.77 if the price breaches the second support level.
CorMedix Inc (NASDAQ: CRMD) Key Stats
With a market capitalization of 887.16 million, the company has a total of 78,789K Shares Outstanding. Currently, annual sales are 43,470 K while annual income is -17,930 K. The company’s previous quarter sales were 104,280 K while its latest quarter income was 108,560 K.
